Therefore, in order to rule out the important role of MCL‐1 in the combined action of these two drugs, we also performed MCL‐1 knockdown followed by drug susceptibility tests on AML cells, but the combined effect of the two did not change significantly. This evidence concerns the gene MCL1 and acute myeloid leukemia.